||Abbreviation title: Rev Diabet Stud
ISSN print edition: 1613-6071
ISSN online edition: 1614-0575
Anders A. Sima, M.D., Ph.D.
Massimo Trucco, M.D.
||Impact Factor (2-yr)*
||Impact Factor (3-yr)*
||Weighted Impact Factor (3-yr)‡
|The Review of Diabetic Studies is a member of CrossRef and indexed in DOD and Medline/Pubmed.
The Review of Diabetic Studies (RDS) is a very carefully edited journal, with each paper provided with a scientific and a linguistic expert throughout the entire reviewing and publication process to serve the author and realize the optimal result for the publication of the paper. The reviewing and proof preparation processes are supervised by the Editor, who personally read and carefully edit any paper published before a final language correction is carried out by a professional, English native-speaking linguist.
The Editors attach importance (1) to the way of presentation of the data and information, which should be substantiated, balanced, and novel, and (2) to the selection of topics to address the most burning questions in diabetes research. As the journal and the publisher are totally dedicated to scientific and charitable interests, and are not afflicted with any commercial interests (in contrast to most other journals), the journal's only goal is the progress in science, which is reflected in the carefully editorial work and the huge effort spent by the Editorial Team in order to create excellence and impact-capturing reference in scientific publishing. The Editors wish to increases attention to unresolved issues that are regarded as most important in scientific progress and clinical translation of therapies aimed at both improving diabetes management and an ultimate cure. The RDS Editorial Board comprises a group of leading experts from the different fields of research into diabetes; they are closely colllaborating to identify the most relevant topics and to organize Paper Series Projects addressing these topics.
The RDS supports and encourages research in biomedical diabetes-related science including areas such as endocrinology, immunology, epidemiology, genetics, cell-based research, developmental research, bioengineering and disease management. The journal publishes original manuscripts on laboratory research, clinical and empirical studies, case and conference reports as well as review and theoretical articles and offers an open forum for immediate discussion of recent advancements by letters and comments. Read more.
The journal supports a fast review process. 95% of all reviews are returned to authors within 2-3 weeks after paper submission.
Statistics about paper acceptance and rejection:
The 2010 rejection rate was: 83.7%
Responsibility for the selection of articles in The RDS remains with the Editorial Board. However, the editors do not assume responsibility for the views and statements expressed by the authors.
The RDS is also available online via DOD (Diabetes Open Directory), a database containing information and publications from diabetes-related biomedical research which is currently in its beta stage.
* 2-yr Impact Factor (IF) is the avarage citation frequency of articles published in The Review of
Diabetic Studies. The 2-yr 2013 IF is calculated by dividing the number of citations in 2013 to
articles published in 2011 and 2012 by the number of articles published in these two years. The
3-yr impact factor refers to articles published in the previous three years.
‡ The 2-yr Weighted Impact Factor (WIF) includes the relation of
citations to the number of published articles in the previous
two years, and the impacts of journals in which the citations took place.
This means that a citation in a journal with a IF higher than the average CF over
all journals (e.g. 1.852 in 2006) increases the WIF
et vice versa. If, for example, the factor is 2, then the citations took place in
journals with a IF 2 times higher than the average CF over all journals. Generally, if the WIF is higher than the
simple citation factor, then the citations took place in journals with an IF higher than the average IF over all journals.
Thus, the factor is a measure for the quality of the citations. The calculation rule is: WIF = (total times of citations x (((times of
citations in journal 1 x IF1) + ... + (times of citations in
journal n x IFn)) divided by (total times of citations x average IF)))
divided by (number of articles published in previous three years). The 3-yer WIF is equally calculated, but refers
to articles published in the last 3 years.
§ The Immediate Citation Factor (ICF) indicates
the level of citations to articles published in the same year. The calculation rule is:
ICF = times of citations in the reported year to articles published in the same
year divided by the number of articles published in this year.